FGL (Fibroblast Growth Loop) vs P21 (Adamax)
Overview
FGL (Fibroblast Growth Loop) and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares FGL (Fibroblast Growth Loop) and P21 (Adamax) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| FGL (Fibroblast Growth Loop) | P21 (Adamax) | |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 100 mcg | 5-20 mg |
| Frequency | daily | intermittent |
| Reported benefits | Enhanced neural plasticity, learning improvement | Enhanced learning, neuroplasticity, memory formation |
| Reported side effects | Minimal side effects | Research compound, limited data |
Key differences
Primary use. FGL (Fibroblast Growth Loop) is categorised under Cognitive Enhancement, while P21 (Adamax) falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. FGL (Fibroblast Growth Loop): not FDA-approved; treated as a research compound. P21 (Adamax): not FDA-approved; treated as a research compound.
Dosing. FGL (Fibroblast Growth Loop) is typically dosed at 100 mcg (daily). P21 (Adamax) is typically dosed at 5-20 mg (intermittent).
Can you stack them?
Some protocols combine peptides, but stacking FGL (Fibroblast Growth Loop) and P21 (Adamax) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between FGL (Fibroblast Growth Loop) and P21 (Adamax)?
- FGL (Fibroblast Growth Loop) and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. FGL (Fibroblast Growth Loop) is not FDA-approved; generally classified as a research compound, whereas P21 (Adamax) is not FDA-approved; generally classified as a research compound.
- What is FGL (Fibroblast Growth Loop) used for?
- NCAM mimetic.
- What is P21 (Adamax) used for?
- Neurogenic peptide.
- Can you take FGL (Fibroblast Growth Loop) and P21 (Adamax) together?
- Some users combine peptides within a single protocol, but stacking FGL (Fibroblast Growth Loop) and P21 (Adamax) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is FGL (Fibroblast Growth Loop) or P21 (Adamax) FDA-approved?
- FGL (Fibroblast Growth Loop) is not FDA-approved; generally classified as a research compound. P21 (Adamax) is not FDA-approved; generally classified as a research compound.
Read the full articles
- FGL (Fibroblast Growth Loop) — full monograph: mechanism, research, dosing & references
- P21 (Adamax) — full monograph: mechanism, research, dosing & references